These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1917056)

  • 41. [Autologous blood transfusion in urology].
    Faul P; Partecke G
    Urologe A; 1989 Mar; 28(2):88-93. PubMed ID: 2470189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
    Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
    Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Heparin elimination and free hemoglobin following cell separation and washing of autologous blood with Cell Saver 4].
    Kling D; Börner U; von Bormann B; Hempelmann G
    Anasth Intensivther Notfallmed; 1988 Apr; 23(2):88-90. PubMed ID: 3394905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
    Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A
    Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous renal cell carcinoma of the kidney and transitional cell carcinoma of the bladder.
    Hasan WA; Al-Bareeq R; Durazi M; Al-Muttawa S
    Can J Urol; 2002 Jun; 9(3):1565-7. PubMed ID: 12121583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Autotransfusion using Cell Saver III. Experience with 90 cases of surgery of the spine in childhood and adolescence].
    Gaudiche O; Loose JP; Egu JF; Dubousset J; Saint-Maurice C
    Cah Anesthesiol; 1988 Oct; 36(6):451-7. PubMed ID: 3214771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
    Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
    Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The place of intra- and postoperative autotransfusion in the exchange of a hip endoprosthesis].
    Lorentz A; Reinhardt M; Andres FJ; Osswald PM; Jani L
    Anaesthesist; 1989 Jan; 38(1):1-9. PubMed ID: 2919746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Microbiological contamination of intraoperatively collected erythrocyte concentrate in mechanical autotransfusion in tumor surgery].
    Wehner M; König F
    Anaesthesiol Reanim; 2001; 26(1):11-7. PubMed ID: 11256126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas.
    Ghossein RA; Bhattacharya S
    Semin Surg Oncol; 2001 Jun; 20(4):304-11. PubMed ID: 11747272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New circulating tumor cell technology could advance personalized medicine in prostate cancer.
    Miller S
    Nanomedicine (Lond); 2013 May; 8(5):683-4. PubMed ID: 23656263
    [No Abstract]   [Full Text] [Related]  

  • 53. Serotonin used as prognostic marker of urological tumors.
    Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
    World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating biomarkers to guide systemic therapy for urothelial carcinoma.
    Abbosh PH; Rosenberg JE; Plimack ER
    Urol Oncol; 2016 Nov; 34(11):502-509. PubMed ID: 27751785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Removal of hepatocarcinoma cells from blood via cell washing and filtration techniques.
    Jones CC; Stammers AH; Fristoe LW; Jones KT; Beck DJ; Pierce ML; Dickes MS
    J Extra Corpor Technol; 1999 Dec; 31(4):169-76. PubMed ID: 10915473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery.
    Karczewski DM; Lema MJ; Glaves D
    Anesth Analg; 1994 Jun; 78(6):1131-5. PubMed ID: 8198270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leucocyte depletion filter removes cancer cells in human blood.
    Kongsgaard UE; Wang MY; Kvalheim G
    Acta Anaesthesiol Scand; 1996 Jan; 40(1):118-20. PubMed ID: 8904269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients.
    Perseghin P; Viganò M; Rocco G; Della Pona C; Buscemi A; Rizzi A
    Vox Sang; 1997; 72(4):221-4. PubMed ID: 9228711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Separation of malignant cells during autotransfusion.
    Dale RF; Kipling RM; Smith MF; Collier DS; Smith PJ
    Br J Surg; 1988 Jun; 75(6):581. PubMed ID: 3395826
    [No Abstract]   [Full Text] [Related]  

  • 60. Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer.
    Miller GV; Ramsden CW; Primrose JN
    Br J Surg; 1991 Jun; 78(6):713-5. PubMed ID: 2070241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.